Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a 3.390% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
[a] N#CC1=C(N2CCOCC2)/C(=C\c2ccccc2)CC1
[b] O=C(NC(Cc1ccccc1)C(=O)O)/C(=C/c1ccco1)NC(=O)c1cccc(Br)c1
[c] COc1ccccc1NS(=O)(=O)c1cccc(NC(=O)c2ccc3ccccc3n2)c1
[d] CC(=O)N1CCN(c2nc(-c3cccs3)nc3ccccc23)CC1
Answer: a. N#CC1=C(N2CCOCC2)/C(=C\c2ccccc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
N#CC1=C(N2CCOCC2)/C(=C\c2ccccc2)CC1
N#CC1=C(N2CCOCC2)/C(=C\c2ccccc2)CC1
(3Z)-3-benzylidene-2-morpholin-4-ylcyclopentene-1-carbonitrile